Debt to EBITDA ratio Analysis of Evaxion Biotech AS - Deep Dive


Debt to EBITDA of EVAX
Dec-23
-0.377
Very Poor Debt to EBITDA
Dec-22
-0.364
Very Poor Debt to EBITDA
Growth
-3.54
%
Debt to EBITDA Analysis of Evaxion Biotech AS
Debt to EBITDA Ratio of EVAX has fallen by -3.54 % Compared to previous Financial Year.
Debt to EBITDA Ratio with value of -0.0012 was highest in Year Dec-20 in last Five Years.
Debt to EBITDA Ratio of EVAX trending down for at least three Years.
Latest Debt to EBITDA Ratio with value of -0.377 is lower than Average Debt to EBITDA of -0.161 in last five years.
Other Debt to EBITDA Related Info of EVAX that may interest you.
Evaxion Biotech AS Overview
CodePricePrevious PricePrice ChangeSector
EVAX3.723.83 2.87 % Biotechnology
Fundamental AnalysisTechnical Analysis
Defination of Debt to EBITDA
The Debt to EBITDA Ratio is a solvency metric that measures the company's ability to meet its debt obligations by earnings before covering its interest, taxes, depreciation, and amortization.    more ..
Debt to EBITDA Formula

Debt to EBITDA Related Ratios
CashFlowFromOperationToDebtDebtToCapitalEVToEBITDA

Tsr Stability Index
Poor Stability Stock
FY - Historical Debt to EBITDA of Evaxion Biotech AS
PeriodDec-23Dec-22Dec-21Dec-20Dec-19Dec-18Dec-17
Debt to EBITDA-0.377-0.364-0.061-0.0012-0.0034-1.570
Change-3.54 %-493.86 %-4939.54 %63.79 %99.79 %
FY Chart of Debt to EBITDA of Evaxion Biotech AS


Note : All Data Generated at the End of Trading Hours (EOD Data)